tiprankstipranks
Trending News
More News >
Vincerx Pharma Inc (VINC)
NASDAQ:VINC
US Market
Advertisement

Vincerx Pharma Inc (VINC) Price & Analysis

Compare
266 Followers

VINC Stock Chart & Stats


Bulls Say, Bears Say

Bulls Say
Analyst PerspectiveAnalyst continues to have a positive view on VINC at current levels despite the challenges.
Clinical TrialsVIP943 has shown favorable safety and tolerability, with no dose-limiting toxicities reported in the 22 patients treated.
Bears Say
Financial PerformanceVINC ended with $10.1M in cash and equivalents, indicating limited financial resources.
Market GuidanceAnalyst is adjusting the price target to $2 from $4.
Strategic DependencyThe company continues to look for a partner to advance development of enitociclib and VIP236, suggesting dependency on external collaboration for progress.

Financials

Options Prices

Currently, No data available
---

Ownership Overview

75.01%4.07%0.03%20.66%
75.01%
Insiders
0.03% Other Institutional Investors
20.66% Public Companies and
Individual Investors

VINC FAQ

What was Vincerx Pharma Inc’s price range in the past 12 months?
Vincerx Pharma Inc lowest stock price was $0.22 and its highest was $19.88 in the past 12 months.
    What is Vincerx Pharma Inc’s market cap?
    Vincerx Pharma Inc’s market cap is $1.44M.
      When is Vincerx Pharma Inc’s upcoming earnings report date?
      Vincerx Pharma Inc’s upcoming earnings report date is May 08, 2025 which is 79 days ago.
        How were Vincerx Pharma Inc’s earnings last quarter?
        Currently, no data Available
        Is Vincerx Pharma Inc overvalued?
        According to Wall Street analysts Vincerx Pharma Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Vincerx Pharma Inc pay dividends?
          Vincerx Pharma Inc does not currently pay dividends.
          What is Vincerx Pharma Inc’s EPS estimate?
          Vincerx Pharma Inc’s EPS estimate is -3.4.
            How many shares outstanding does Vincerx Pharma Inc have?
            Vincerx Pharma Inc has 5,234,000 shares outstanding.
              What happened to Vincerx Pharma Inc’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of Vincerx Pharma Inc?
              Among the largest hedge funds holding Vincerx Pharma Inc’s share is Woodline Partners LP. It holds Vincerx Pharma Inc’s shares valued at 0.

                Company Description

                Vincerx Pharma Inc

                Vincerx Pharma Inc. (VINC) is a clinical-stage biopharmaceutical company focused on developing innovative therapies to address unmet medical needs in oncology. The company primarily operates in the biotechnology sector, concentrating on a robust pipeline of targeted small molecules and antibody-drug conjugates designed to treat various forms of cancer. Vincerx's core strategy involves leveraging its deep scientific expertise to create novel treatment options that improve patient outcomes and quality of life.
                Similar Stocks
                Company
                Price & Change
                Follow
                Windtree Therapeutics
                ReShape Lifesciences
                Universe Pharmaceuticals
                iSpecimen
                Onconetix
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis